Literature DB >> 1782132

Nutritional assessment of infants with cystic fibrosis diagnosed through screening.

E H Mischler1, M S Marcus, S A Sondel, A Laxova, P Carey, R Langhough, P M Farrell.   

Abstract

Presymptomatic infants diagnosed through neonatal screening for cystic fibrosis can have biochemical evidence of malnutrition. With aggressive dietary management and treatment with pancreatic enzymes, normal biochemical indices of nutrition can be achieved at 12 months of life in most cases. Males with cystic fibrosis appear to be more at risk than females for abnormal growth and biochemical indices of nutrition in the first year of life. This may be related to the observed decrease in fat intake when compared to females. Males, especially, should be carefully observed for development of nutritional abnormalities based on this data. Careful attention should be paid to vitamin E and essential fatty acid status in all CF infants. The numbers in this study are small and the long-term consequences of early nutritional intervention await the conclusion of the randomized, controlled study on-going in Wisconsin.

Entities:  

Mesh:

Year:  1991        PMID: 1782132     DOI: 10.1002/ppul.1950110712

Source DB:  PubMed          Journal:  Pediatr Pulmonol Suppl        ISSN: 1054-187X


  4 in total

1.  Normal growth in cystic fibrosis associated with a specialised centre.

Authors:  C E Collins; L MacDonald-Wicks; S Rowe; E V O'Loughlin; R L Henry
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

2.  Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.

Authors:  André M Cantin; Terry B White; Carroll E Cross; Henry Jay Forman; Ronald J Sokol; Drucy Borowitz
Journal:  Free Radic Biol Med       Date:  2006-09-29       Impact factor: 7.376

Review 3.  Newborn screening for cystic fibrosis.

Authors:  Kevin W Southern; Marieke M E Mérelle; Jeannette E Dankert-Roelse; A D Nagelkerke
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

Review 4.  Antioxidant supplementation for lung disease in cystic fibrosis.

Authors:  Oana Ciofu; Sherie Smith; Jens Lykkesfeldt
Journal:  Cochrane Database Syst Rev       Date:  2019-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.